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Abstract
Context—Black South African women are less insulin sensitive than their white counterparts,
despite less central and greater peripheral fat deposition. We hypothesized that this paradox may
be explained, in part, by differences in the adipogenic capacity of subcutaneous adipose tissue
(SAT).
Objective—To measure adipogenic and lipogenic gene expression in abdominal and gluteal SAT
depots, and determine their relationships with insulin sensitivity (SI) in South African women.
Design—Cross-sectional.
Participants—14 normal-weight (BMI <25 kg/m2) black, 13 normal-weight white, 14 obese
(BMI >30 kg/m2) black and 13 obese white premenopausal South African women.
Main outcomes—SI (frequently sampled intravenous glucose tolerance test) in relation to
expression of adipogenic and lipogenic genes in abdominal and gluteal SAT depots.
Results—With increasing BMI, black women had less visceral fat (P=0.03) and more abdominal
(P=0.017) and gynoid (P=0.041) SAT but had lower SI (P<0.01) than white women. The
expression of adipogenic and lipogenic genes was proportionately lower with obesity in black, but
not white women in the gluteal and deep SAT depots (P<0.05 for ethnicity x BMI effect). In black
women only, the expression of these genes correlated positively with SI (all P<0.05),
independently of age and fat mass.
Conclusions—Obese black women have reduced SAT expression of adipogenic and lipogenic
genes compared to white women, which associates with reduced SI. These findings suggest that
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obesity in black women impairs SAT adipogenesis and storage, potentially leading to insulin
resistance and increased risk of type 2 diabetes.
Keywords
insulin sensitivity; ethnicity; adipogenesis; lipogenesis; adipose tissue distribution; hypertrophic
obesity
INTRODUCTION
Despite a high prevalence of insulin resistance, black South African women have less
visceral adipose tissue (VAT) (1) and more peripheral (gluteal-femoral) subcutaneous
adipose tissue (SAT) than their white counterparts (2). While increased VAT is considered a
major determinant of insulin resistance (3), peripheral SAT deposition has been shown to be
‘protective’ (4), being inversely associated with fasting insulin levels in overweight and
obese white premenopausal women (5). The mechanisms underlying this apparent paradox
are not known.
The adipogenic capacity of SAT has been proposed as a potential mechanism underlying the
link between adiposity and insulin resistance. Reduced adipogenic capacity of SAT is
typically associated with increased adipose cell size (6), apoptosis, inflammation, reduced
vascularization and insulin signaling within adipose tissue (7) and peripheral insulin
resistance (8). As adipogenesis is controlled by a sequential activation of transcription
factors, in particular, peroxisome proliferator-activated receptor γ (PPARγ) and CCAAT/
enhancer-binding protein α (C/EBPα), which function with other adipogenic transcription
factors, including sterol regulatory element-binding protein 1 (SREBP1), to regulate the
expression of lipogenic genes such as lipoprotein lipase (LPL), fatty acid synthase (FASN),
fatty acid binding protein 4 (FABP4) and adiponectin (9), we hypothesized that a reduction
in these genes may be associated with insulin resistance in black South African women.
Therefore, we sought to measure expression of genes involved in adipogenesis and
lipogenesis in abdominal and gluteal SAT depots and determine their relationships with
insulin sensitivity in normal-weight and obese black and white South African women.
METHODS AND PROCEDURES
The study population consisted of 14 normal-weight (BMI <25 kg/m2) black, 13 normal-
weight white, 14 obese (BMI >30 kg/m2) black and 13 obese white pre-menopausal South
African women, who were recruited by advertisement as previously described (1, 10).
Briefly, inclusion criteria were: (i) age 18-45 years; (ii) no known diseases and not taking
medication for any other metabolic diseases; (iii) not currently pregnant or lactating; and (iv)
of South African ancestry. The study was approved by the Human Research Ethics
Committee of the Faculty of Health Sciences of the University of Cape Town, and all
subjects gave written informed consent.
The testing procedures, including the assessment of body composition, insulin sensitivity
and adipose tissue biopsies, have been previously reported (1, 10). In brief, body fatness and
gynoid fat mass (11), were assessed using dual-energy-X-ray absorptiometry (DXA,
Discovery-W, Software version 4.40, Hologic Inc., Bedford, MA, USA), and abdominal
VAT, deep SAT (DSAT) and superficial SAT (SSAT) areas was assessed by computerized
tomography (CT, Toshiba X-press Helical Scanner, Japan). The insulin sensitivity index (SI)
was quantified using Bergman’s minimal model of glucose kinetics (12) from an insulin-
modified frequently sampled intravenous glucose tolerance test (FSIGT) .
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Fat biopsies were obtained from the abdominal DSAT, SSAT and gluteal areas by mini-
liposuction and used to measure adipocyte area and gene expression (10). Total RNA was
isolated using the Qiagen RNeasy system (Qiagen Ltd, Crawley, UK). RT-PCR was
performed in triplicate using a Roche LightCycler®480 (Roche Diagnostics Ltd, Burgess
Hill, UK) with gene specific primers (Invitrogen Ltd, Paisley, UK) and fluorescent probes
from either the Roche Universal Probe Library system or predesigned assays from Applied
Biosystems (Warrington, UK) (Supplementary Table 1). Transcript levels are presented as
the ratio of abundance of the gene of interest: mean of abundance of PPIA, 18S and RPLO.
Results are presented as means ± standard error (SE). Differences in mRNA levels between
ethnicity and BMI groups within each SAT depot were analyzed using two-way ANOVA
with Bonferroni post-hoc analysis, with and without covarying for age and SI. Partial
correlations, adjusting for age and fat mass, were used to explore the associations between
gene expression and measures of insulin sensitivity in both black and white women. The
interaction between gene expression and ethnicity on insulin sensitivity was tested using
multiple regression, including age and fat mass as covariates. Data were analyzed using
STATISTICA version 10 (Statsoft Inc., Tulsa, OK).
RESULTS
Subject characteristics
The characteristics of the subjects have been described in detail previously (1, 10, 14). In
brief, black and white women were well matched for % body fat and waist circumference,
while obese black women had less VAT and more SSAT than white women, but similar
DSAT. After adjusting for total fat mass, obese black women had greater gynoid fat mass
(DXA-derived) than obese white women (P=0.041), which correlated inversely with SI in
black (r=-0.44, p=0.033) but not white women (r=0.29, p=0.22). Fasting glucose levels were
not different between ethnic groups, but black women had higher fasting insulin levels and a
lower SI than white women. Circulating adiponectin levels did not differ by ethnicity, nor
did average abdominal and gluteal adipocyte size. There was no difference in the proportion
of subjects with a family history of diabetes.
Adipose tissue gene expression
Transcript levels of adipogenic and lipogenic genes in adipose tissue depots are presented in
Figure 1. There were significant ethnicity x BMI interactions for SREBP1 (P=0.041) and
FASN (P=0.017) in the DSAT depot; and for PPARγ (P=0.004), PEPCK (P=0.017) and
FABP (P=0.017) in the gluteal depot, such that mRNA levels were significantly reduced
with obesity in black, but not white women. These interactions were also significant after
covarying for SI. Adiponectin mRNA levels in both DSAT and gluteal depots trended to
decrease to a greater extent with obesity in black compared to white women after covarying
for SI (P=0.054, P=0.060, respectively). No ethnicity x BMI interactions were observed in
the SSAT depot.
Obesity also had effects independently of ethnicity. Within the gluteal depot only, mRNA
levels of all adipogenic transcription factors were lower in obese compared to normal-
weight women (all P<0.05), whereas in all SAT depots, mRNA levels of all lipogenic genes
were significantly lower in obese compared to normal weight women (all P<0.05).
Associations between adipose tissue gene expression and insulin sensitivity
In black but not white women, SI correlated positively with the expression of genes involved
in adipogenesis: CEBPα (r=0.47, P=0.023 and r=-0.04, P=0.869) and PPARγ (r=0.40,
P=0.057 and r=-0.00, P=0.992), lipogenesis: FASN (r=0.52, P=0.011 and r=0.33, P=0.135),
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LPL (r=0.50, P=0.015 and r=-0.15, P=0.493), FABP (r=0.46, P=0.027 and r=-0.42,
P=0.052) and adiponectin (r=0.44, P=0.034 and r=-0.09, P=0.707) in the gluteal depot, and
SREBP1 (r=0.431, P=0.040 and r=0.01, P=0.953) and FASN (r=0.519, P=0.011 and r=0.33,
P=0.135) in the DSAT depot, respectively. In contrast, in white but not black women, SI
correlated negatively with FABP mRNA levels in the SSAT depot (r=-0.434, P=0.044 and
r=0.20, P=0.354). These associations did not however differ by ethnicity (P>0.05 for
ethnicity x mRNA).
DISCUSSION
The novel findings of the study were that the expression of PPARγ and PPARγ-responsive
genes were down-regulated to a greater extent with obesity in black compared to white
women. Further, the expression of these genes, mainly in the gluteal and DSAT depots, was
associated with insulin sensitivity in black, but not white women.
In support of previous studies (15), we showed that the expression of adipogenic and
lipogenic genes was down-regulated with obesity in SAT of both black and white women.
Decreased expression of these genes may represent an adaptive process limiting further
accumulation of fat mass. However, our observation that the expression of PPARγ and
PPARγ-responsive genes was down-regulated to a greater extent with obesity in black
compared to white women, suggests an ethnic-specific adaptation. These findings
corroborate those of Smith et al. (16) who showed lower expression of genes regulating
adipogenesis and lipogenesis (PPARγ, lipin-1, AGPAT2, SCD1 and ATGL) in abdominal
SAT of African American than Caucasian women who were similarly obese and insulin
resistant. Reduced expression of adipogenic and lipogenic genes has also been reported in
insulin resistant compared to insulin sensitive subjects (6, 17, 18). Accordingly, we found
expression of the major adipogenic transcription factors (PPARγ and CEBPα) and PPARγ-
responsive genes (FASN, LPL, FABP and adiponectin) were correlated with insulin
sensitivity in black, but not white women.
Notably, these gene associations with insulin sensitivity were only significant in the gluteal,
and to a lesser extent, the DSAT depot. These findings are of particular relevance as we
have previously shown that insulin sensitivity in this cohort of black women was most
closely associated with CT-determined DSAT area, whereas in the white women, VAT area
was the most significant correlate of insulin sensitivity (14). We now show for the first time
that gynoid fat mass was negatively correlated with insulin sensitivity in black, but not white
women, contrasting to the prevailing hypothesis that peripheral (gluteal-femoral) SAT
deposition is ‘protective’ (as reviewed in Manolopoulos et al. (4)). However, to our
knowledge, these studies have only been undertaken in Caucasian populations, and it is not
yet known whether the associations are consistent in other ethnic groups. We propose that
increased gluteal fat deposition in black South African women is associated with down-
regulation of PPARγ and PPARγ-responsive genes, thereby reducing insulin sensitivity.
The mechanism whereby the expression of adipogenic and lipogenic genes are down-
regulated is most likely mediated by higher levels of inflammation. In obese black women
we have shown higher SAT expression of chemokines and cytokines than in white women,
with highest expression in the gluteal depot (10). Cytokines, in particular, tumor necrosis
factor-α (TNFα) have been shown to inhibit adipogenesis by suppressing the induction of
PPARγ and C/EBPα and maintaining the activation of the Wnt-signalling pathway (19), as
well as inhibiting the expression of lipogenic genes including LPL and FABP (20).
This study has a few limitations. The study is limited by a small sample size, and larger
studies are required to verify the findings in both black and white women and determine
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whether the relationships are ethnic-specific. The cross-sectional nature limits inferences
about causality. We did not measure protein levels, or have a direct measure of
adipogenesis. Despite marked ethnic differences in the expression of PPARγ and PPARγ-
responsive genes, we did not show ethnic differences in mean adipocyte size measured in
frozen sections, perhaps due to limitations of the method, as the size distribution of the
adipocytes may be more important than the mean cell size (18).
In conclusion, compared to white women, obese black women have impaired SAT
expression of PPARγ and PPARγ-responsive genes, and this is particularly the case in the
gluteal SAT. These changes in gene expression are associated with a reduction in insulin
sensitivity. These findings add to the weight of evidence refuting the hypothesis that black
women display ‘healthy obesity’ due to their greater peripheral fat distribution, but rather
suggest that obesity in black South African women impairs gluteal SAT adipogenesis and
storage, potentially leading to insulin resistance and an increased risk of type 2 diabetes.
Prospective studies including a larger sample are now justified to extend these findings.
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Figure 1. Expression of adipogenic and lipogenic genes in abdominal deep (DSAT) and
superficial subcutaneous (SSAT) and gluteal (GLUT) adipose tissue depots in normal weight and
obese black and white women.
Bars represent means ± SE. * P<0.01, black vs. white; λ P<0.05, obese vs. normal weight; #
P<0.05, ethnicity x BMI interaction effect (obese black women significantly different from
all other groups). C/EBPB, CCAAT/enhancer binding protein β; C/EBPA, CCAAT/
enhancer binding protein α; SREBP1, sterol regulatory element-binding protein 1; PPARγ,
peroxisome proliferator activated receptor γ; FASN, fatty acid synthase; FABP4, fatty acid
binding protein 4; LPL, lipoprotein lipase; PEPCK, phosphoenolpyruvate carboxykinase.
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